Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis

PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oman J Ophthalmol
Asıl Yazarlar: Al-Amri, Abdulrahman Mohammed, Fiorentini, Sandra Flavia, Albarry, Maan A., Bamahfouz, Ashjan Yousef
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657154/
https://ncbi.nlm.nih.gov/pubmed/29118487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ojo.OJO_232_2014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller